Common cancer symptoms like lumps are rarely associated with a Stage 0 cancer diagnosis – meaning they're almost exclusively ...

BOSTON & MONTREAL, June 04, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, ...

May 22, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

ImmunoPrecise Antibodies Ltd. (IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary LENSaitm ...

Gene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today announced the appointment of Amy Pott as Chief Global Commercialization Officer. In this role, Ms. Pott will serve as ...

"We’ve always been close as sisters and I felt fortunate to have her by my side that day. I’m grateful for her support all through the treatment that followed." ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

“With a potentially best-in-class bladder cancer therapy and two de-risked rare disease programs, Protara has the opportunity to meaningfully impact patient outcomes,” said Mr. Conkling.“I look ...